Replies to post #171957 on Amarin Corp Plc (AMRN)

[Jvee]

Points taken but we can assume that overall revenue run rate post 2029 will / should decline, otherwise why would BPs be concerned with their products going generic?

Yes potentially there may be other drugs deprived from V for an acquirer but that potential will factor little if any in a BO price.

[HDGabor]

v-

generics may not be able to offer a significantly lower price

There is a room …

COGS: $30
Net Revenue (currently): $125
Gross Profit: $95

(per 120 caps … wasn't based on recent 10-Qs)

Best,
G